Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.

Clarke DK, Nasar F, Chong S, Johnson JE, Coleman JW, Lee M, Witko SE, Kotash CS, Abdullah R, Megati S, Luckay A, Nowak B, Lackner A, Price RE, Little P, Kalyan N, Randolf V, Javadian A, Zamb TJ, Parks CL, Egan MA, Eldridge J, Hendry M, Udem SA.

J Virol. 2014 Jun;88(12):6690-701. doi: 10.1128/JVI.03441-13. Epub 2014 Apr 2.

2.

Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression.

Witko SE, Johnson JE, Kalyan NK, Felber BK, Pavlakis GN, Sidhu MK, Hendry RM, Udem SA, Parks CL.

J Virol Methods. 2010 Mar;164(1-2):43-50. doi: 10.1016/j.jviromet.2009.11.023. Epub 2009 Nov 24.

3.

Prime-boost vaccination with recombinant mumps virus and recombinant vesicular stomatitis virus vectors elicits an enhanced human immunodeficiency virus type 1 Gag-specific cellular immune response in rhesus macaques.

Xu R, Nasar F, Megati S, Luckay A, Lee M, Udem SA, Eldridge JH, Egan MA, Emini E, Clarke DK.

J Virol. 2009 Oct;83(19):9813-23. doi: 10.1128/JVI.00550-09. Epub 2009 Jul 22.

4.

In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Johnson JE, Coleman JW, Kalyan NK, Calderon P, Wright KJ, Obregon J, Ogin-Wilson E, Natuk RJ, Clarke DK, Udem SA, Cooper D, Hendry RM.

Vaccine. 2009 May 14;27(22):2930-9. doi: 10.1016/j.vaccine.2009.03.006. Epub 2009 Mar 13.

5.

Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses.

Billeter MA, Naim HY, Udem SA.

Curr Top Microbiol Immunol. 2009;329:129-62. Review.

PMID:
19198565
6.

Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.

Cooper D, Wright KJ, Calderon PC, Guo M, Nasar F, Johnson JE, Coleman JW, Lee M, Kotash C, Yurgelonis I, Natuk RJ, Hendry RM, Udem SA, Clarke DK.

J Virol. 2008 Jan;82(1):207-19. Epub 2007 Oct 17.

7.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.

Vaccine. 2007 Oct 10;25(41):7132-44. Epub 2007 Aug 21.

PMID:
17850933
8.

Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.

Parks CL, Latham T, Cahill A, O'neill RE, Passarotti CJ, Buonagurio DA, Bechert TM, D'Arco GA, Neumann G, Destefano J, Arendt HE, Obregon J, Shutyak L, Hamm S, Sidhu MS, Zamb TJ, Udem SA.

Virology. 2007 Oct 25;367(2):275-87. Epub 2007 Jun 28. Erratum in: Virology. 2008 May 10;374(2):535-9.

9.

Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag.

Coleman JW, Ogin-Wilson E, Johnson JE, Nasar F, Zamb TP, Clarke DK, Hendry RM, Udem SA.

J Virol Methods. 2007 Jul;143(1):55-64. Epub 2007 Mar 26.

PMID:
17382412
10.

Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.

Kowalski J, Adkins K, Gangolli S, Ren J, Arendt H, DeStefano J, Obregon J, Tummolo D, Natuk RJ, Brown TP, Parks CL, Udem SA, Long D.

Vaccine. 2007 Mar 8;25(12):2296-305. Epub 2006 Dec 12.

PMID:
17239997
11.

Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.

Clarke DK, Nasar F, Lee M, Johnson JE, Wright K, Calderon P, Guo M, Natuk R, Cooper D, Hendry RM, Udem SA.

J Virol. 2007 Feb;81(4):2056-64. Epub 2006 Dec 6.

12.

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.

Johnson JE, Nasar F, Coleman JW, Price RE, Javadian A, Draper K, Lee M, Reilly PA, Clarke DK, Hendry RM, Udem SA.

Virology. 2007 Mar 30;360(1):36-49. Epub 2006 Nov 13.

13.

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector.

Clarke DK, Cooper D, Egan MA, Hendry RM, Parks CL, Udem SA.

Springer Semin Immunopathol. 2006 Nov;28(3):239-53. Epub 2006 Sep 15. Review.

PMID:
16977404
14.

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

Natuk RJ, Cooper D, Guo M, Calderon P, Wright KJ, Nasar F, Witko S, Pawlyk D, Lee M, DeStefano J, Tummolo D, Abramovitz AS, Gangolli S, Kalyan N, Clarke DK, Hendry RM, Eldridge JH, Udem SA, Kowalski J.

J Virol. 2006 May;80(9):4447-57.

15.

An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development.

Witko SE, Kotash CS, Nowak RM, Johnson JE, Boutilier LA, Melville KJ, Heron SG, Clarke DK, Abramovitz AS, Hendry RM, Sidhu MS, Udem SA, Parks CL.

J Virol Methods. 2006 Jul;135(1):91-101. Epub 2006 Mar 29.

PMID:
16569439
16.

Inhibition of measles virus minireplicon-encoded reporter gene expression by V protein.

Witko SE, Kotash C, Sidhu MS, Udem SA, Parks CL.

Virology. 2006 Apr 25;348(1):107-19. Epub 2006 Jan 30.

17.

Role of V protein RNA binding in inhibition of measles virus minigenome replication.

Parks CL, Witko SE, Kotash C, Lin SL, Sidhu MS, Udem SA.

Virology. 2006 Apr 25;348(1):96-106. Epub 2006 Jan 25.

18.

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.

Buonagurio DA, Bechert TM, Yang CF, Shutyak L, D'Arco GA, Kazachkov Y, Wang HP, Rojas EA, O'Neill RE, Spaete RR, Coelingh KL, Zamb TJ, Sidhu MS, Udem SA.

Vaccine. 2006 Mar 15;24(12):2151-60. Epub 2005 Nov 21.

PMID:
16413951
19.

Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting.

Buonagurio DA, O'Neill RE, Shutyak L, D'Arco GA, Bechert TM, Kazachkov Y, Wang HP, DeStefano J, Coelingh KL, August M, Parks CL, Zamb TJ, Sidhu MS, Udem SA.

Virology. 2006 Apr 10;347(2):296-306. Epub 2006 Jan 18.

20.

Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates.

Lin YH, Deatly AM, Chen W, Miller LZ, Lerch R, Sidhu MS, Udem SA, Randolph VB.

Virus Res. 2006 Jan;115(1):9-15. Epub 2005 Aug 11.

PMID:
16099066
21.

Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.

Egan MA, Chong SY, Megati S, Montefiori DC, Rose NF, Boyer JD, Sidhu MK, Quiroz J, Rosati M, Schadeck EB, Pavlakis GN, Weiner DB, Rose JK, Israel ZR, Udem SA, Eldridge JH.

AIDS Res Hum Retroviruses. 2005 Jul;21(7):629-43.

PMID:
16060834
22.

Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes.

Egan MA, Chong SY, Rose NF, Megati S, Lopez KJ, Schadeck EB, Johnson JE, Masood A, Piacente P, Druilhet RE, Barras PW, Hasselschwert DL, Reilly P, Mishkin EM, Montefiori DC, Lewis MG, Clarke DK, Hendry RM, Marx PA, Eldridge JH, Udem SA, Israel ZR, Rose JK.

AIDS Res Hum Retroviruses. 2004 Sep;20(9):989-1004.

PMID:
15585086
23.

Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors.

Vasilakis N, Falvey D, Gangolli SS, Coleman J, Kowalski J, Udem SA, Zamb TJ, Kovacs GR.

Nat Biotechnol. 2003 Aug;21(8):932-5. Epub 2003 Jul 6.

PMID:
12845329
24.

Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors.

Kovacs GR, Parks CL, Vasilakis N, Udem SA.

J Virol Methods. 2003 Jul;111(1):29-36.

PMID:
12821194
25.

Identification and characterization of a regulatory domain on the carboxyl terminus of the measles virus nucleocapsid protein.

Zhang X, Glendening C, Linke H, Parks CL, Brooks C, Udem SA, Oglesbee M.

J Virol. 2002 Sep;76(17):8737-46.

26.

Expression of a foreign gene by recombinant canine distemper virus recovered from cloned DNAs.

Parks CL, Wang HP, Kovacs GR, Vasilakis N, Kowalski J, Nowak RM, Lerch RA, Walpita P, Sidhu MS, Udem SA.

Virus Res. 2002 Feb 26;83(1-2):131-47.

PMID:
11864746
27.

Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.

Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, Udem SA.

J Virol. 2001 Jan;75(2):921-33.

28.

Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, Udem SA.

J Virol. 2001 Jan;75(2):910-20.

29.

Crystal structure of the oligomerization domain of NSP4 from rotavirus reveals a core metal-binding site.

Bowman GD, Nodelman IM, Levy O, Lin SL, Tian P, Zamb TJ, Udem SA, Venkataraghavan B, Schutt CE.

J Mol Biol. 2000 Dec 15;304(5):861-71.

PMID:
11124032
30.

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE Jr, Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, Wittek AE, Casey R, Eichelberger M, Thumar B, Randolph VB, Udem SA, Chanock RM, Murphy BR.

J Infect Dis. 2000 Nov;182(5):1331-42. Epub 2000 Sep 22.

PMID:
11010838
31.

Rescue of mumps virus from cDNA.

Clarke DK, Sidhu MS, Johnson JE, Udem SA.

J Virol. 2000 May;74(10):4831-8.

32.

Enhanced measles virus cDNA rescue and gene expression after heat shock.

Parks CL, Lerch RA, Walpita P, Sidhu MS, Udem SA.

J Virol. 1999 May;73(5):3560-6.

33.
34.

Vaccine-associated measles pneumonitis in an adult with AIDS.

Angel JB, Walpita P, Lerch RA, Sidhu MS, Masurekar M, DeLellis RA, Noble JT, Snydman DR, Udem SA.

Ann Intern Med. 1998 Jul 15;129(2):104-6. No abstract available.

PMID:
9669968
35.

A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells.

Hsu EC, Sarangi F, Iorio C, Sidhu MS, Udem SA, Dillehay DL, Xu W, Rota PA, Bellini WJ, Richardson CD.

J Virol. 1998 Apr;72(4):2905-16.

36.

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

Karron RA, Buonagurio DA, Georgiu AF, Whitehead SS, Adamus JE, Clements-Mann ML, Harris DO, Randolph VB, Udem SA, Murphy BR, Sidhu MS.

Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13961-6.

37.

Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene.

Sidhu MS, Chan J, Kaelin K, Spielhofer P, Radecke F, Schneider H, Masurekar M, Dowling PC, Billeter MA, Udem SA.

Virology. 1995 Apr 20;208(2):800-7.

38.
39.

Canine distemper virus L gene: sequence and comparison with related viruses.

Sidhu MS, Menonna JP, Cook SD, Dowling PC, Udem SA.

Virology. 1993 Mar;193(1):50-65.

PMID:
8438585
40.

Retraction. Infectious measles virus from cloned cDNA.

Eschle D, Cattaneo R, Schmid A, Metzler M, Chan J, Pifko-Hirst S, Udem SA, Billeter MA.

EMBO J. 1991 Nov;10(11):3558. No abstract available.

41.

Regulatory effects of persistent measles virus infection on tumorigenicity and protooncogene expression in neuroblastoma cells.

Wolfson M, Gopas J, Katorza A, Udem SA, Segal S, Rager-Zisman B.

Cancer Detect Prev. 1991;15(3):171-6.

PMID:
2059960
42.
43.

Infectious measles virus from cloned cDNA.

Ballart I, Eschle D, Cattaneo R, Schmid A, Metzler M, Chan J, Pifko-Hirst S, Udem SA, Billeter MA.

EMBO J. 1990 Feb;9(2):379-84. Retraction in: Eschle D, Cattaneo R, Schmid A, Metzler M, Chan J, Pifko-Hirst S, Udem SA, Billeter MA. EMBO J. 1991 Nov;10(11):3558.

44.

Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases.

Cattaneo R, Schmid A, Spielhofer P, Kaelin K, Baczko K, ter Meulen V, Pardowitz J, Flanagan S, Rima BK, Udem SA, et al.

Virology. 1989 Dec;173(2):415-25.

PMID:
2596022
45.

Proliferative membranopathy and human immunodeficiency virus in AIDS hearts.

Flomenbaum M, Soeiro R, Udem SA, Kress Y, Factor SM.

J Acquir Immune Defic Syndr. 1989;2(2):129-35.

PMID:
2539451
46.
47.
48.

Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line.

Sheppard RD, Raine CS, Bornstein MB, Udem SA.

Proc Natl Acad Sci U S A. 1986 Oct;83(20):7913-7.

49.

Measles virus matrix protein synthesized in a subacute sclerosing panencephalitis cell line.

Sheppard RD, Raine CS, Bornstein MB, Udem SA.

Science. 1985 Jun 7;228(4704):1219-21.

PMID:
4001938
50.

Supplemental Content

Support Center